APOH and COVID-19: Differences between HCPs and the COVID-19 group II patients were found for aCL IgA, anti-β2GPI IgA, aPS/PT IgG, and aPS/PT IgA, and between HCPs and COVID-19 group III patients for aCL IgG, IgM, and IgA.